SB 6088 – WashingtonStatus: Inactive / Dead
Year Introduced: 2020
Establishing a prescription drug affordability board. Subject to appropriation, the Prescription Drug Affordability Board (Board) is
established. The Board consists of five members appointed by the Governor who have expertise in health care economics or clinical medicine. The Board may establish advisory groups of relevant stakeholders. HCA must provide administrative support to the Board and any advisory groups. The Board must coordinate with and complement the work of HCA, other boards, and work groups related to prescription drug costs and emerging therapies. By May 1, 2021, the Board must provide the Health Care Cost Transparency Board with recommendations for the means and methodologies to establish a cost growth benchmark related to prescription drugs. Status: Vetoed by Governor.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.